|
CDK8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.70189999987502E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.55140000000143E-05 |
| Normal-vs-Stage2 |
1.002960E-03 |
| Normal-vs-Stage3 |
8.09789999500765E-08 |
| Normal-vs-Stage4 |
1.80655999999502E-05 |
| Stage1-vs-Stage2 |
9.617400E-01 |
| Stage1-vs-Stage3 |
3.266300E-02 |
| Stage1-vs-Stage4 |
2.619200E-01 |
| Stage2-vs-Stage3 |
1.278990E-01 |
| Stage2-vs-Stage4 |
3.325800E-01 |
| Stage3-vs-Stage4 |
6.313400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.16569999944971E-07 |
| Normal-vs-AfricanAmerican |
3.535600E-03 |
| Normal-vs-Asian |
3.412100E-04 |
| Caucasian-vs-AfricanAmerican |
7.687200E-01 |
| Caucasian-vs-Asian |
8.442400E-01 |
| AfricanAmerican-vs-Asian |
8.946800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.510969999996E-05 |
| Normal-vs-Female |
6.6024000000553E-07 |
| Male-vs-Female |
7.163000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.389420E-04 |
| Normal-vs-Age(41-60Yrs) |
5.75960000026576E-07 |
| Normal-vs-Age(61-80Yrs) |
7.34969999971469E-07 |
| Normal-vs-Age(81-100Yrs) |
4.316500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.632400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.193800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.072600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.575800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.651600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.209800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.875200E-01 |
| Classical-VS-Follicular |
9.766200E-01 |
| Classical-VS-Other |
3.814800E-01 |
| Classical-VS-Normal |
3.24699999998401E-06 |
| Tall-VS-Follicular |
4.696400E-01 |
| Tall-VS-Other |
6.587800E-01 |
| Tall-VS-Normal |
1.987360E-04 |
| Follicular-VS-Other |
4.509200E-01 |
| Follicular-VS-Normal |
5.219200E-04 |
| Other-VS-Normal |
1.067560E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.44320000020571E-07 |
| Normal-vs-N1 |
2.06209999997764E-06 |
| N0-vs-N1 |
3.207000E-01 |
|
|
